Universidad Pública de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies

    British Journal of Cancer, Vol. 130, Núm. 5, pp. 869-879

  2. PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets

    EMBO Molecular Medicine, Vol. 16, Núm. 8, pp. 1791-1816

2022

  1. Clinical landscape of LAG-3-targeted therapy

    Immuno-Oncology and Technology, Vol. 14

  2. Cutting-Edge CAR Engineering: Beyond T Cells

    Biomedicines, Vol. 10, Núm. 12

2021

  1. A proteomic atlas of lineage and cancer-polarized expression modules in myeloid cells modeling immunosuppressive tumor-infiltrating subsets

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  2. Hyperprogressive disease: Main features and key controversies

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

  3. Understanding lag-3 signaling

    International Journal of Molecular Sciences, Vol. 22, Núm. 10